Clifutinib Besylate for the treatment of AML Phase I clinical trial
| Title | Clifutinib Besylate for the treatment of AML Phase I clinical trial |
|---|---|
| Description | Data on genetic results and statistical analysis data from Phase I clinical trials of Clifutinib Besylate for the treatment of AML. |
| Organism | Homo sapiens |
| Data Type | Non-coding RNA Profiling by NGS |
| Data Accessibility | Controlled-access |
| BioProject | PRJCA030197 |
| Release Date | 2024-10-01 |
| Submitter | zhijie wang (wangzhijie@hec.cn) |
| Organization | Guangdong Dongyangguang Pharmaceutical Co., Ltd |
| Submission Date | 2024-09-14 |
The data cannot be downloaded as it has not yet been registered in the Human Genetic Resource Management Platform of MOST.
| File ID | File Title | Number/Samples | File Type | File Size | File Suffix | Download Times | Download |
|---|---|---|---|---|---|---|---|
| OMIX007388-01 | Genetic result data and statistical analysis data | 1 | Non-coding RNA Profiling by NGS | 224.4 KB | xlsx | 0 | Unavailable |